Want to see AGL full AI Analyst Report?
AGL Stock Chart & Stats
$30.05
$0.02(1.16%)
At close: 4:00 PM EST
$30.05
$0.02(1.16%)
Day’s Range― - ―
52-Week Range$7.48 - $125.71
Previous CloseN/A
Volume1.09M
Average Volume (3M)292.41K
Market Cap
$1.87B
Enterprise Value$1.64B
Total Cash (Recent Filing)$231.41M
Total Debt (Recent Filing)$33.40M
Price to Earnings (P/E)―
Beta2.50
Next Earnings
Aug 05, 2026EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-22.70
Shares Outstanding16,683,786
10 Day Avg. Volume330,135
30 Day Avg. Volume292,414
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.25
Price to Sales (P/S)0.05
P/FCF Ratio-2.40
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue0.28
Enterprise Value/Gross Profit-10.28
Enterprise Value/Ebitda-4.81
Forecast
1Y Price Target
$57.15Price Target Upside90.20% Upside
Rating ConsensusHold
Number of Analyst Covering15
EPS Forecast (FY)-2.83
Revenue Forecast (FY)$5.72B
Bulls Say, Bears Say
Bulls Say
Value-based Care PlatformAgilon’s core model—capitated payments and a physician-aligned enabling platform—creates recurring, contract-driven revenue and aligns incentives with providers. This structure supports durable margins if care management reduces total cost of care and sustains shared savings over multiple years.
Experienced New CEO AppointmentA CEO with deep Medicare Advantage and provider-integration experience strengthens strategic execution and payer relationships. His track record and long-term, equity-linked incentives increase the odds of disciplined scaling, contract wins, and operational improvements that persist beyond short-term cycles.
Relatively Low LeverageModest debt levels provide financial flexibility to absorb cash volatility while investing in care management and contracting. Lower leverage reduces refinancing risk and preserves optionality for strategic moves, making the company better positioned to execute a multi-quarter turnaround if operational trends improve.
Bears Say
Negative Gross Profit And Persistent LossesNegative gross profit indicates the core care-management economics are not yet sustainable: revenues have not consistently covered direct medical costs. Persistent operating losses erode equity and hinder the company’s ability to reinvest in programs that drive longer-term margin recovery without external support.
Weak Cash GenerationConsistent negative operating and free cash flow constrains capital for clinical scaling, technology and contracting initiatives. Continued cash burn elevates refinancing or dilution risk and limits the firm’s ability to withstand adverse claims trends or invest opportunistically over the coming 2–6 months.
Declining Medicare Advantage MembershipA shrinking MA membership base erodes revenue scale and weakens risk pooling benefits central to capitation economics. Sustained membership declines reduce bargaining leverage with payors and limit the platform’s ability to spread fixed costs, impeding durable margin improvement and growth.
Agilon Health News
AGL FAQ
What was Agilon Health Inc’s price range in the past 12 months?
Agilon Health Inc lowest stock price was $7.48 and its highest was $125.71 in the past 12 months.
What is Agilon Health Inc’s market cap?
Agilon Health Inc’s market cap is $1.87B.
When is Agilon Health Inc’s upcoming earnings report date?
Agilon Health Inc’s upcoming earnings report date is Aug 05, 2026 which is in 26 days.
How were Agilon Health Inc’s earnings last quarter?
Agilon Health Inc released its earnings results on May 06, 2026. The company reported $2.94 earnings per share for the quarter, beating the consensus estimate of $1.041 by $1.899.
Is Agilon Health Inc overvalued?
According to Wall Street analysts Agilon Health Inc’s price is currently Undervalued.
Does Agilon Health Inc pay dividends?
Agilon Health Inc pays a Quarterly dividend of $0.45 which represents an annual dividend yield of N/A. See more information on Agilon Health Inc dividends here
What is Agilon Health Inc’s EPS estimate?
Agilon Health Inc’s EPS estimate is 0.11.
How many shares outstanding does Agilon Health Inc have?
Agilon Health Inc has 16,683,786 shares outstanding.
What happened to Agilon Health Inc’s price movement after its last earnings report?
Agilon Health Inc reported an EPS of $2.94 in its last earnings report, beating expectations of $1.041. Following the earnings report the stock price went up 117.81%.
Which hedge fund is a major shareholder of Agilon Health Inc?
Currently, no hedge funds are holding shares in AGL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Agilon Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$57.15 (90.20% Upside)
$57.15 (90.20% Upside)
Blogger Sentiment
Bullish
AGL Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 10.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 26.4%
Last 30 Days ▲ 26.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.09%
12-Months-Change
Fundamentals
Return on Equity
-146.01%
Trailing 12-Months
Asset Growth
-22.14%
Trailing 12-Months
Company Description
Agilon Health Inc
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the company served an approximate total of 238,000 senior clients. This figure included 186,300 individuals enrolled in Medicare Advantage plans and 51,700 recipients of Medicare fee-for-service benefits. The enterprise, which commenced operations in 2016, was initially incorporated as Agilon Health Topco, Inc. before rebranding to its current name, agilon health, inc., in March 2021. Its corporate headquarters are situated in Austin, Texas.
AGL Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a balanced message: strong operational execution and meaningful near-term wins (data pipeline, risk adjustment upside, improved medical margin, scaled clinical programs and a sizable Q1 adjusted EBITDA beat) were tempered by structural challenges — notably a sizable year-over-year MA membership decline, a YoY revenue decline, Part D reserving uncertainty, cautious early-year cost recording, and conservative full-year adjusted EBITDA guidance. Management emphasized disciplined, sustainable growth and quality-driven improvements rather than aggressive expansion, resulting in positive operational momentum but continued near-term prudence and uncertainty.View all AGL earnings summariesAGL Stock 12 Month Forecast
Average Price Target
$57.15
▲(90.20% Upside)
Technical Analysis
AMN Healthcare Services
―
Cross Country Healthcare
―
InnovAge Holding
―
P3 Health Partners
―
biote
―
Ownership Overview
5.67% Insiders
16.61% Mutual Funds
38.20% Other Institutional Investors
29.58% Public Companies and
Individual Investors